Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107194733 | 10719473 | 3 | F | 2014 | 20151130 | 20150119 | 20160726 | PER | US-UNITED THERAPEUTICS-UNT-2014-004204 | UNITED THERAPEUTICS | 0.00 | A | F | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107194733 | 10719473 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.140 ?G/KG/MIN, CONTINUING | 21272 | .14 | UG/KG | INJECTION | |||||||
| 107194733 | 10719473 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | 0.179 ?G/KG/MIN, CONTINUING | 21272 | .179 | UG/KG | INJECTION | ||||||||
| 107194733 | 10719473 | 3 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 6 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 7 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 8 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 9 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 10 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
| 107194733 | 10719473 | 11 | C | LETAIRIS | AMBRISENTAN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107194733 | 10719473 | 1 | Pulmonary arterial hypertension |
| 107194733 | 10719473 | 3 | Product used for unknown indication |
| 107194733 | 10719473 | 4 | Product used for unknown indication |
| 107194733 | 10719473 | 5 | Product used for unknown indication |
| 107194733 | 10719473 | 6 | Product used for unknown indication |
| 107194733 | 10719473 | 7 | Product used for unknown indication |
| 107194733 | 10719473 | 8 | Product used for unknown indication |
| 107194733 | 10719473 | 9 | Product used for unknown indication |
| 107194733 | 10719473 | 10 | Product used for unknown indication |
| 107194733 | 10719473 | 11 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107194733 | 10719473 | Abdominal distension | |
| 107194733 | 10719473 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107194733 | 10719473 | 1 | 20100219 | 0 | ||
| 107194733 | 10719473 | 2 | 20100219 | 0 |